Stefan Glück, MD, PhD is a Medical Oncologist with focus on solid tumors including brain cancer activities worldwide. Additionally, he is responsible for Immuno-Oncology programs in solid tumors and hematologic diseases and is in the area of Early Assets. He completed his medical studies at the University of West Berlin, Germany in 1978 followed by a medical oncology & bone marrow transplant fellowship in Toronto, Canada. Before becoming V.P. of Global Medical Affairs at Celgene Corp., he previously served as Sylvester Professor of Medicine at the Miller School of Medicine in Miami, Florida until 2014. From 2009-2010 he was Assistant Director of the Sylvester Comprehensive Cancer Center & Associate Chief, for the Division of Hematology & Medical Oncology and from 2003-2008 he served as Clinical Director of the Braman Family Breast Cancer Institute in Miami, Florida. He has authored and co-authored over 260 articles, and has written more than 350 papers at national and international meetings.